Sony SH800SFP cell sorter maintenance agreement for ncats (POP - 5/24/2021 to 5/23/2022)
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00240
- Awardee
-
Sony Biotechnology Inc. UEI DQF2MP5BTAW7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $109,745
Award facts
- Contract value 79% obligated
-
- $109,744.50 Current, with exercised options
- $138,675.74 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $27,554 | |
| Exercise an Option | $26,241 | |
| Exercise an Option | $25,727 | |
| Other Administrative Action | $0 | |
| Original award | $30,223 |
About this award
The National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, has awarded a $138,675.74 firm-fixed-price purchase order to Sony Biotechnology Inc. for a one-year maintenance agreement on a SONY SH800SFP cell sorter. This sole-source acquisition does not have a set-aside designation. As a manufacturer of flow cytometry and imaging instrumentation, Sony Biotechnology has been awarded numerous prime federal contracts to provide specialized laboratory equipment and associated services, particularly for biomedical research across agencies like the National Institutes of Health. This maintenance agreement ensures reliable operation of the critical cell sorting instrument used in NCATS' programs studying disease, developing therapies, and advancing scientific knowledge.
Quick answers
Who was awarded contract 75N95021P00240?
75N95021P00240 was awarded to Sony Biotechnology Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 24, 2021.
How much is contract 75N95021P00240 worth?
The government has obligated $109,745 on 75N95021P00240. Its potential value, with all options, is $138,676.
Which agency awarded contract 75N95021P00240?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00240, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00240 competed?
The extent of competition for 75N95021P00240 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award